Results 121 to 130 of about 26,059 (187)

Beyond the States: Developing a Discrete Event Simulation Model Using R. [PDF]

Pharmacoeconomics
Lin Z, Briggs A.
europepmc   +1 more source

Pharmacoeconomics and the medicinal chemist.

ACS Medicinal Chemistry Letters, 2014
C. Lindsley
semanticscholar   +1 more source

Correction: Health-related quality of life among multiethnic public polyclinic users in Singapore and associated factors: a cross-sectional study. [PDF]

Qual Life Res
Cheng LJ, Lee JGJ, Chern CWJ, Cheng JY, Thakumar AV, Luo N, Koh GCH, Ng QX.   +7 more
europepmc   +1 more source

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study. [PDF]

Clinicoecon Outcomes Res
Alruthia Y, Alhajri H, Almohammed OA, Balkhi B, Alsaqa'aby MF, Almuqbil MA, Al-Abdulkarim HA, Almutairi AR.   +7 more
europepmc   +1 more source

Authors' Reply: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study. [PDF]

Epidemiol Health
Lee H, Hong B, Tzu-Ting Su C, Bea S, Jeong HE, Jung K, Cheng MC, Chang ZC, Lai EC, Lee J.   +9 more
europepmc   +1 more source

Value of Clinical Evidence and Health Economics and Outcomes Research (HEOR) Studies. [PDF]

Muscle Nerve
Abrahao A, Ciepielewska M, Zinman L.
europepmc   +1 more source

Individualized Treatment Rules Based on Cost-Effectiveness Criteria in Microsimulations. [PDF]

Pharmacoeconomics
Meier N, Quiroga Gutierrez AC, Pletscher M, Schwenkglenks M.   +3 more
europepmc   +1 more source

Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes. [PDF]

Pharmacoeconomics
Killedar A, Howell M, Howard K, Norris S.   +3 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain. [PDF]

Pharmacoecon Open
Romero Jiménez RM, Herranz Pinto P, Campos Domínguez M, Bellmunt A, Vidal-Vilar N, Fortes Soto MDP, De Lossada Juste A.   +6 more
europepmc   +1 more source

Correction: From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment. [PDF]

Pharmacoecon Open
Ferrario L, Menzaghi B, Rizzardini G, Roccia A, Garagiola E, Bellavia D, Schettini F, Foglia E.   +7 more
europepmc   +1 more source